Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007
Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001
Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
Intake of n -3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021
Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004
The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006
Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Source: Eur Respir J 2007; 29: 958-964 Year: 2007
Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007
Effect of omega-3 and phosphoethanolamine in patients with asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021
Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
Decreased levels of high-density lipoprotein cholesterol in patients with sarcoidosis and relationship with disease activity Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004
Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006
Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
The effect of dietary fatty acids on respiratory infection in human lung cells Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018
Plasma fatty acids in asthmatic children of Northern Greece Source: Eur Respir J 2001; 18: Suppl. 33, 453s Year: 2001
The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017
Prenatal exposure to n-6/n-3 fatty acids, trace elements and minerals and risk of atopic disease in childhood: birth cohort study Source: Eur Respir J 2003; 22: Suppl. 45, 564s Year: 2003
Muscle energy metabolism and plasma amino acids level in patients with chronic respiratory impairment Source: Eur Respir J 2002; 20: Suppl. 38, 289s Year: 2002
Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007